Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CMM.V gold miner/producer set to take off
http://www.bloomberg.com/apps/news?pid=20601082&sid=aopFrnQmfT0g
web: http://www.centurymining.com/
chart: http://stockcharts.com/h-sc/ui?s=cmm.v&p=D&yr=0&mn=3&dy=0&id=p73718857718
dd: http://www.stockigloo.com/
Happy Thanksgiving to all
Thats great. I'm locked and loaded and not even thinking of
selling any till at least a dollar.
Not at all. Just wishfull thinkng.
and the day after that and so and so on.
Anticipation!!!!!!!!!!!
NNLX .58
Looking good Rig.
Not so slow anymore.
Looks like the train is departing. Now .535
NNLX .525 to .53
NNLX .515 to .525
May the force be with you.
A little more volume and we should move up fast.
Just finished listening to the presentation. Did I hear
correctly that they'd already shipped 1 million units??
Agree with you Rig. Doin the same with IWEB, URST and ALLRF.
Don't know if NNLX can do it today. But imagine it will be
making new highs in the next few weeks.
Nice. Should continue to climb slowly as production nears.
Baby steps.
NNLX .442.
Looking for more this time once clean room is finished,
machines installed and production begins. Will also be
nice once they announce who customers are.
Yep. Getting real close.
NNLX .41 to .44
News!
NanoLogix Files International Patent Applications, Reclaims 18 Existing Patents, Noted in Department of Defense Quarterly Publication and Provides Operations Update
9:45 AM ET, November 3, 2009
HUBBARD, OH, Nov 03, 2009 (MARKETWIRE via COMTEX) -- NanoLogix, Inc. (PINKSHEETS: NNLX) announces that the company has recently filed BNP(TM) (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%.
At the company's September 25th shareholder meeting, the support for all proposals presented by the company for shareholder approval was overwhelmingly positive, with all shareholder-rights/takeover-defense plan proposals receiving 98-99% of the 64 million shares voted out of roughly 101 million shares outstanding.
The company has reclaimed full rights to 18 patents previously licensed to Nutra Pharma Corporation after failure of Nutra Pharma to pay the balance of patent royalties due for 2008 and the first half of 2009. Nutra Pharma was served notice of their default in July. NanoLogix has returned the 18 patents to the company portfolio and will pursue development and marketing of select technological aspects of the patents.
NanoLogix's April press release: "New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague," was highlighted in the latest issue of the Department of Defense Quarterly, "CBRNIAC," from the Chemical, Biological, Radiological and Nuclear Defense Information Analysis Center. The publication can be accessed at: https://www.cbrniac.apgea.army.mil/Products/Newsletter/Pages/default.aspx
NanoLogix has received notification from New Brunswick Scientific of a November 20th shipping date for ordered production equipment for its cleanroom production facility at the company's Hubbard, Ohio headquarters. This order consists of four machines for production of BNP rapid-detection kits and is anticipated to be the first of many for kit production.
NanoLogix management, staff, and directors would like to congratulate Corporate Counsel David R. Barnhizer for his recent three-year appointment as Visiting Professor to the University of Westminster, London. Professor Barnhizer will continue as corporate counsel.
About NanoLogix, Inc.
NanoLogix is a biotechnology company focused primarily on medical diagnostics. Its products offer accelerated detection and identification of microorganisms present in infectious and non-infectious human diseases. In addition to medical, National Defense, and Homeland Security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.
Patents pending or granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and bioreactor-based hydrogen generation.
More information on NanoLogix is available at: www.nanologix.com
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contact:NanoLogix, Inc.Investor RelationsCarol SurrenaTelephone: 330-534-0800E-mail: Email Contact
Thanks
Hey mikeyk thats great news. Let us know if it continues
to get better. I also suffer from psoriasis and the
cortison cremes I use don't work very well anymore,
which I was told would jappen eventually.
Thanks for your response parentsgratae. Looking forward to
that.
Nice... Looks like I might have to start raising my stink bids. 1 day closer to completion.
Thanks lockshed I'm just glad I stumbled on to this company
now and not after production and sales begin. What a bargain.
Agree PG. I'm the one who's been jumping the bid by .001
last week and this week. Slowly accumulating here.
Stumbled accross this gem on the NPHC board and like
the potential here.
Patience..........
So do I. Thanks to whomever for the cheapies today.
OOOPS!
Stayfocused better recalculate your figures, its $18.99/unit
not $2.
Nutra Pharma Blog updated
http://www.nutrapharma.com/blog/
Agreed.......
Agreed. Looking forward to TSX listing and drill results this
fall/winter. Glad I got in recently and looking to buy more
while were still under a buck.
Now theres someone with a lot of conviction. 10,000 shares LOL
Hey Clay could you please provide an Annotated Chart for
NPHC.
Hey Clay, new here. I know this isn't a nasdeq stock but
could you do me a favor and check out the chart for
GLG.TO. Looks ready to break out.
That usually works for me when I really want to fill my
order. Place an order at the ask then cancell it soon after.
Especially if the price is stalled there for a while.
2009 Bond back up to 98.50
2009 Bond 95.25